Background/Aims: To review cases of fetal/newborn goiter due to excess maternal iodine ingestion. Methods: We reviewed the medical records of all patients that presented with congenital goiter in 2003. We used the PubMed search engine to conduct a review of publications addressing congenital goiter and excessive iodine intake. Results: Maternal ingestion of large amounts of iodine due to an error in the manufacturing of a prenatal vitamin caused a goiter in her fetus. Seven other women who received the same prenatal vitamin had newborn children with goiters. Three of these children were hypothyroid at the time of initial examination. Three patients (2 hypothyroid and 1 euthyroid) had thyroid scans with radioactive iodine; iodine uptake was elevated (>80%) in all 3, and in 1 the perchlorate washout test was positive. Conclusion: The finding of congenital goiter and increased iodine uptake in a newborn is considered diagnostic of dyshormonogenesis, a permanent form of hypothyroidism. Our description is important because it demonstrates that iodine excess during pregnancy may mimic some forms of dyshormonogenesis. The differentiation between the two causes of newborn goiter may prevent the lifelong use of supplemental levothyroxine in patients with a transient abnormality.

Keywords:
Congenital goiter, Maternal iodine, Hypothyroidism, Vitamin supplement
1.
Escobar GM, Obregón MJ, Del Rey FE: Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia. J Clin Endocrinol Metab 2000;85:3975–3987.
2.
Escobar GM, Obregón MJ, Del Rey FE: Role of thyroid hormone during early brain development. Eur J Endocrinol 2004;151:U25–U37.
3.
Escobar GM, Obregón MJ, Del Rey FE: Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 2004;18:225–248.
4.
Glinoer D: Pregnancy and iodine. Thyroid 2001;11:471–481.
5.
Glinoer D: What happens to the normal thyroid during pregnancy? Thyroid 1999;9:631–635.
6.
Glinoer D: The regulation of thyroid function during normal pregnancy: importance of iodine nutrition status. Best Pract Res Clin Endocrinol Metab 2004;18:133–152.
7.
Larsen PR, Davies TF, Schlumberger MJ, Hay ID: Thyroid physiology and diagnostic evaluation of patients with thyroid disease; in Williams Textbook of Endocrinology, ed 10. Philadelphia, Saunders, 2003, pp 348–351.
8.
Assessment of iodine deficiency disorders and monitoring their elimination. WHO/ICCIDD/UNICEF manual. www.indorgs.virginia.edu/iccidd/aboutidd.htm.
9.
Roti E, Vagenakis AG: Effect of excess iodide: clinical aspects; in Braverman LE, Utiger RD (eds): The Thyroid, ed 8. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 316–329.
10.
Teng W, Shan Z, Teng X, Guan H, Li Y, Teng Di, et al: Effect of iodine intake on thyroid disease in China. N Engl J Med 2006;354:2783–2793.
11.
Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P: Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metabol 2002;87:4462–4469.
12.
Pedersen IB, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L: Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. J Clin Endocrinol Metabol 2006;91:3830–3834.
13.
Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE: Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999;140:3404–3410.
14.
De Wolf D, De Schepper J, Verhaaren H, Deneyer M, Smitz J, Sacre-Smits L: Congenital hypothyroid goiter and amiodarone. Acta Paediatr Scand 1988;77:616–618.
15.
Bostanci I, Sarioglu A, Ergin H, Aksit A, Cinbis M, Akalin N: Neonatal goiter caused by expectorant usage. J Pediatr Endocrinol Metab 2001;14:1161–1162.
16.
Vincens-Calvet E, Potau N, Carreras E, et al: Diagnosis and treatment in utero of goiter with hypothyroidism caused by iodide overload. J Pediatr 1998;133:147–148.
17.
Grosso S, Berardi R, Cioni M, et al: Transient neonatal hypothyroidism after gestational exposure to amiodarone: follow up of two cases. J Endocrinol Invest 1998;21:699.
18.
Nishiyama S, Mikeda T, Okada T, Nakamura K, Kotani T, Hishinuma A: Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake. Thyroid 2004;14:77–83.
19.
Hassan AI, Aref GH, Kassem AS: Congenital iodide-induced goitre with hypothyroidism. Arch Dis Child 1968;43:702–704.
20.
Carswell F, Kerr MM, Hutchison JH: Congenital goitre and hypothyroidism produced by maternal ingestion of iodides. Lancet 1970;13:1241–1243.
21.
Fisher DA, Oddie TH, Wait JC: Thyroid function tests. Findings in Arkansas children and young adults. Am J Dis Child 1964;107:282–287.
22.
Takashima S, Nomura N, Tanaka H, Itoh Y, Miki K, Harada T: Congenital hypothyroidism: assessment with ultrasound. Am J Neuroradiol 1995;16:1117–1123.
23.
Serreau R, Polack M, Leger J, Vuillard E, Thurninger O, Chemouny S, Heid M, Guibourdenche J, Jacqz-Aigrain E, Oury JF, Luton D: Fetal thyroid goiter after massive iodine exposure. Prenat Diagn 2004;24:751–753.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.